VERRULIA is a homeopathic medicine traditionally used in the treatment of warts.
Instructions VERRULIA
Dosage VERRULIA
Drug for use in adults and children over 6 years.
1 lozenge every morning and evening for 1 month.
If symptoms persist after one month of treatment, medical advice is needed.
In case of aggravation, consult your doctor.
Method and route of administration VERRULIA
Orally.
Lozenge.
Duration of treatment VERRULIA
30 days treatment.
In case of overdose VERRULIA
If you have taken more VERRULIA, lozenge that you should:
Consult your doctor or pharmacist immediately.
In case of failure of one or more doses of VERRULIA
If you forget to take VERRULIA, lozenge:
Do not take a double dose to make up for the dose that you forgot to take
Pregnancy and lactation with VERRULIA
Ask your doctor or pharmacist before taking any medicine.
In the absence of experimental and clinical data, and as a precautionary measure, the use of this drug should be avoided during pregnancy and lactation.
Composition VERRULIA
Excipients with known effect: sucrose, lactose,
Active substances:
Antimonium crudum 9 CH ............... 1 mg
Nit ac .................... 9 CH 1 mg
Thuja occidentalis 9 CH ................. 1 mg
For a tablet.
Other substances: sucrose, lactose, magnesium stearate.
Cons-indication VERRULIA
Never use VERRULIA, lozenge:
In children less than 6 years due to risk of aspiration related to the dosage form.
Possible interactions with VERRULIA
If you are taking or have recently taken any other medicines, including medicines obtained without a prescription, talk to your doctor or pharmacist.
This medication should be taken without food.
Adverse VERRULIA
Like all medicines, VERRULIA orodispersible tablets may cause side effects, although not everybody will not matter.
If you notice any side effects not listed in this leaflet, or if the side effects gets serious, please tell your doctor or pharmacist.
Storage conditions VERRULIA
No special precautions for storage.
Precautions and warnings VERRULIA
Be careful with VERRULIA, lozenge:
· Due to the presence of lactose, this drug should not be used in patients with congenital galactosemia, malabsorption of glucose and galactose or lactase deficiency.
· Due to the presence of sucrose, this drug should not be used in case of fructose intolerance, malabsorption of glucose and galactose or sucrase-isomaltase (rare metabolic diseases).